Biologic therapy in type 2 CRSwNP: from immunopathology to clinical management

Wei He, Yu Jiang, Rongrong Ge, Shuo Wu

Open source

DOI: 10.1007/s00011-026-02399-z
Published: 2026-10-27
Container: Inflammation Research
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00011-026-02399-z,
  title = {Biologic therapy in type 2 CRSwNP: from immunopathology to clinical management},
  author = {Wei He and Yu Jiang and Rongrong Ge and Shuo Wu},
  year = {2026},
  journal = {Inflammation Research},
  doi = {10.1007/s00011-026-02399-z},
  url = {https://doi.org/10.1007/s00011-026-02399-z}
}

RIS

TY  - JOUR
TI  - Biologic therapy in type 2 CRSwNP: from immunopathology to clinical management
AU  - Wei He
AU  - Yu Jiang
AU  - Rongrong Ge
AU  - Shuo Wu
PY  - 2026
JO  - Inflammation Research
DO  - 10.1007/s00011-026-02399-z
UR  - https://doi.org/10.1007/s00011-026-02399-z
ER  -

APA

He, W., Jiang, Y., Ge, R., & Wu, S. (2026). Biologic therapy in type 2 CRSwNP: from immunopathology to clinical management. Inflammation Research. https://doi.org/10.1007/s00011-026-02399-z

Source records

crossref · retrieved 2026-11-08T07:32:06.517Z